Skip to main content

Upcoming presentations/meetings

2021-08-10
Interim report for January - June 2021
2021-09-01
Pareto Securities Annual Healthcare Conference
2021-11-09
Interim report for January - September 2021

Previous presentations/meetings

2021-06-02
Redeye Growth Day
2021-05-26
BioStock Life Science Summit
2021-05-11
Redeye Investor Forum
2021-05-11
Interim report for January - March 2021

2021-03-25
Redeye Investor Forum

Link to presentation
2021-02-10
Swiss Nordic Bio 2021

2021-02-09
Year-end report for the financial year 2020

2020-12-08
Laikas Investerarjakten Live, Stockholm

2020-11-26
Redeye Life Science Day, Stockholm
2020-11-25
Market update - Moberg Pharma and of the subsidiary OncoZenge
2020-11-17
BioStock Life Science Summit, Stockholm
2020-11-10
Interim report for July 2019 - September 2020

2020-09-01
LSX Nordic Congress Virtual
2020-08-11
Interim report for July 2019 - June 2020

2020-06-02
Redeye Growth Day, Stockholm

2020-05-12
Interim report for July 2019 - March 2020

2020-02-11
Interim report for July - December 2019

2020-01-22
Press conference, January 22, 2020

2020-01-13
JP Morgan Healthcare Conference, San Francisco, January 13-16
2019-12-05
The Nordic-American Life Science Conference, New York
2019-11-19
Redeye Life Science Day, Stockholm
2019-11-19
Interim report for July - September 2019

2019-10-30
General Shareholders Meeting

General Shareholders meeting was held in Bromma, Sweden on October 30, 2019.
2019-09-05
Pareto Health Care Conference, Stockholm
2019-08-29
Year-end report for the financial year January - June 2019

2019-08-29
Redeye Investor lunch, Stockholm
2019-05-15
General Shareholders Meeting

Moberg Pharma´s General Shareholders Meeting was held in Bromma, Sweden on May 15, 2019.
2019-05-14
Interim report for January - March 2019

2019-03-15
Extraordinary General Meeting

Moberg Pharma´s Extraordinary General Meeting was held in Bromma, Sweden on March 15 at 3 p.m.
2019-03-04
Nordea Life Science Day, Stockholm
2019-03-04
Information document

The information document has been prepared by reason of the divestment of the OTC-business in Moberg Pharma. The information document describes the transaction as well as Moberg Pharmas continued operations following a divestment of the commercial operations. In addition, the information document contains certain financial information for 2018 prepared on a pro forma basis. The information document is available in Swedish only, but an English translation of the pro forma information is available.

Information document (Swedish only)
Pro forma (English translation)
2019-02-12
Year-end report for the fiscal year 2018

2019-02-12
Information meeting regarding Moberg Pharma´s divestment of the OTC business

2019-01-07
JP Morgan Healthcare Conference, San Francisco
2018-12-04
Redeye Investor After Work, Stockholm
2018-11-29
The Nordic-American Life Science Conference, New York
2018-11-21
Redeye Life Science Day, Stockholm
2018-11-06
Interim report for January - September 2018

2018-09-06
Pareto Healthcare Day, Stockholm
2018-09-04
Redeye Early Bird, Stockholm
2018-08-20
Investment meeting at Nordea, Stockholm
2018-08-07
Interim report for January - June 2018

2018-06-04
BIO International Convention in Boston, June 4-7
2018-05-22
Redeye Investor After Work, Stockholm
2018-05-17
Non-deal Roadshow, Geneva and Zürich

2018-05-16
Presentation at ABGSC, Stockholm

2018-05-15
General Shareholders Meeting

Moberg Pharma´s General Shareholders Meeting was held in Bromma, Sweden on May 15, 2018
2018-05-08
Interim report for January - March 2018

2018-03-20
Redeye Investor After Work, Stockholm
2018-03-15
Carnegie Nordic Healthcare Seminar, Stockholm